1
EXHIBIT 10.17
AMENDMENT XX. 0
XX
XXXXXXXX XXXXXXXXX XX. X0000
BETWEEN
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
AND
SPECTRUMEDIX CORP
(FORMERLY PREMIER AMERICAN TECHNOLOGIES CORPORATION)
THIS AGREEMENT by and between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA,
BERKELEY ("California") and SPECTRUMEDIX CORP. ("SpectruMedix") is hereby
amended as follows:
ARTICLE I. STATEMENT OF THE WORK
California shall perform additional work as more fully described in
Exhibit B, attached hereto.
I) ARTICLE II. PERIOD OF PERFORMANCE
The period of performance of this agreement is extended for one year, and
now shall be from December 1, 1996, through February 28, 1999, unless
sooner terminated or extended as elsewhere provided herein.
II) ARTICLE III. COST AND PAYMENT
The amount of this agreement is increased by ** to **. Payment of this
additional ** will be made to California within 30 days of receipt of
California's monthly invoices for cost incurred. Payment should be sent to
Financial Services, 000 Xxxxxxxxxx Xxxx, Xxxxxxxx, XX 00000-0000.
III) ARTICLE X. NOTICES
When any notice to SpectruMedix is to be given hereunder, it shall be in
writing and sent to the following addresses:
SpectruMedix Corporation
0000 Xxx Xxxxxxxxx Xxxx
Xxxxx Xxxxxxx, XX 00000
Attention: Xx. Xxxxxx Xxxxxxxxxx or Xx. Xxxxxxx Xxxxxxxxxxxx
* Indicates that material has been omitted and confidential treatment has
been requested therefor. All such omitted material has been separately filed
with the Securities and Exchange Commission pursuant to Rule 24b-2.
2
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed
by their duly authorized representatives.
SPECTRUMEDIX CORPORATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
("SPECTRUMEDIX") ("CALIFORNIA")
By: /s/ Xxxxxx X. Xxxxxxxxxx By:/s/ Xxxxxx X. Xxxxx
Name: Xxxxxx X. Xxxxxxxxxx Name: Xxxxxx X. Xxxxx
Title: C.E.O. Title: Manager,
University/Industry Research
Date: April 2, 1998 Date: March 1, 1998
------------- -------------
* Indicates that material has been omitted and confidential treatment has
been requested therefor. All such omitted material has been separately filed
with the Securities and Exchange Commission pursuant to Rule 24b-2.
3
1998 BUDGET AND STATEMENT OF WORK (SPECTRUMEDIX SRC AWARD #M2498):
BIOMEDICAL APPLICATIONS OF IMPROVE ISOTOPE RATIO MEASUREMENTS WITH MAGNETIC
SECTOR MASS SPECTROMETERS
*** ENTIRE SCHEDULE REDACTED ***
* Indicates that material has been omitted and confidential treatment has
been requested therefor. All such omitted material has been separately filed
with the Securities and Exchange Commission pursuant to Rule 24b-2.
4
Budget
I) PERSONNEL Salary + Fringe Benefits
** TABLE REDACTED **
II) SUPPLIES (to be covered by other mechanisms)
III) MISCELLANEOUS
A) Publications, graphics, etc. **
B) Clerical, telephone, etc. **
C) Travel **
--
Subtotal **
--
Subtotal **
Indirect costs:
** TABLE REDACTED **
GRAND TOTAL **
* Indicates that material has been omitted and confidential treatment has
been requested therefor. All such omitted material has been separately filed
with the Securities and Exchange Commission pursuant to Rule 24b-2.
5
BUDGET JUSTIFICATION
IV) PERSONNEL
** PARAGRAPHS REDACTED **
V) SUPPLIES
** PARAGRAPHS REDACTED **
VI) MISCELLANEOUS
Self-explanatory
* Indicates that material has been omitted and confidential treatment has
been requested therefor. All such omitted material has been separately filed
with the Securities and Exchange Commission pursuant to Rule 24b-2.
